Trial Profile
Comparison of combined oral contraceptive Yasmin and Cyproteron compound on Hirsutism and androgens in women with a polycystic ovary syndrome
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; Ethinylestradiol/cyproterone
- Indications Hirsutism
- Focus Pharmacodynamics
- 15 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials record.
- 19 Apr 2012 New trial record